Investigation of MicroRNA 196a2 polymorphism with Thalassemia Disease among Middle and South Iraqi Population
DOI:
https://doi.org/10.35516/jmj.v59i2.1980Keywords:
β-thalassemia, polymorphism, miRNA, rs11614913Abstract
Background Beta-thalassemia is widely recognized as a prevalent genetic hematologic disease. The condition is characterized by a decrease or absence in the synthesis of a specific globin chain, leading to the development of varying degrees of hemolytic anemia and its associated consequences. MicroRNAs (miRNAs) play a significant role in the reactivation of globin expression in individuals with thalassemia. However, the transcriptional patterns of miRNAs in thalassemia have not yet been determined.
The aim of the study: This study examines the polymorphism of miRNA 196a2 in people diagnosed with thalassemia.
Method: The present investigation comprised a sample size of 100 individuals diagnosed with thalassemia in conjunction with an equivalent number of control samples. Samples were collected from patients at the thalassemia center at Babylon Hospital from May 2021 to August 2021. These samples were obtained to assess materiality and pediatrics in Babylon provinces and Iraq in the year 2021.
Results: The findings of the current study demonstrate a significant association between persons possessing the dominant model genotype (TT., TT+TC) and an increased susceptibility to thalassemia disease, compared to patients with the recessive model genotype (CC, TC+TT) (P value = 0.032, OR = 1.85, CI 95% (1.05-3.27).
Conclusions: To our knowledge, this investigation represents the initial examination that establishes a correlation between miRNAs, the rs11614913 single nucleotide polymorphism (SNP), and thalassemia. This study posits that there may be an association between the miRNA196a2 rs11614913 T>C variant T>C and susceptibility to beta-thalassemia illness in the middle and southern Iraqi population. Additional research involving many centers is required to validate our findings. The results suggest that variations in the target sites of the miRNA rs11614913 SNP of miRNA rs11614913 inside genes associated with thalassemia may play a role in modifying the severity of thalassemia phenotypes.
References
Cao A, Galanello R. Beta-thalassemia (2010). Genetics IN Medicine • Volume 12, Number 2, February 2010
Harbi NS, Jawad AH, Alsalman FK. Evaluation of adipokines concentration in Iraqi patients with major and minor beta-thalassemia. Rep Biochem Mol Biol. 2020;9(2):209-215.
Cappellini MD, Viprakasit V, Taher AT, et al. A phase 3 trial of luspatercept in patients with transfusion-dependent beta-thalassemia. N Engl J Med. 2020;382(13):1219-1231
Chuang JC, Jones PA. Epigenetics and microRNAs. Pediatr Res. 2007;61:24-29.
De Dreuzy E, Bhukhai K, Leboulch P, Payen E. Current and future alternative therapies for beta-thalassemia major. Biomed J. 2016;39(1):24-38.
Mansilla-Soto J, Riviere I, Boulad F, Sadelain M. Cell and gene therapy for the beta-thalassemias: advances and prospects. Hum Gene Ther. 2016;27(4):295-304.
Pasricha SR, Frazer DM, Bowden DK, Anderson GJ. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with beta-thalassemia major: a longitudinal study. Blood. 2013;122(1):124-133.
Thompson AA, Walters MC, Kwiatkowski J, et al. Gene therapy in patients with transfusion-dependent beta-thalassemia. N Engl J Med. 2018;378(16):1479-1493.
Nuntakarn L et al. Blood Cells, Mol Dis. 2009: 42:1. [PMID:18951049] Musallam KM et al. Cold Spring Harb Perspect Med. 2012: 2:7. [PMID: 22762026]
Elisavet M and Zissimos M “A human, ATP-independent, RISC Assembly machine fueled by pre-miRNA,” Genes & Development, 2005:vol. 19, no. 24, pp. 2979–2990.
Farashi, S; H. Najmabadi, Diagnostic pitfalls of less well recognized HbH disease, Blood Cells Mol. Dis.(2015) ;55 :387–395
Sankaran,V.G ; Xu,J; Orkin, S.H .Advances in the understanding of hemoglobin switching, Br. J. Haematol. (2010);149: 181–194.
Sankaran, V.G J. Xu, R. Byron, H.A. Greisman, C. Fisher, D.J. Weatherall, et al., A functional element necessary for fetal hemoglobin silencing, N. Engl. J. Med. 365 (2011) :807–814.
Chuang JC, Jones PA. Epigenetics and microRNAs. Pediatr Res. 2007;61:24-29.
Wang H, Wang H, Duan X, Liu C, Li Z. Digital quantitative analysis of microRNA in single cell based on ligation-depended polymerase colony (Polony). Biosens Bioelectron. 2017;95:146-151.
Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350 355.
Akhtar MM ; Micolucci,L ; Islam,M.S; Olivieri,F; Procopio, A.D .Bioinformatic tools for microRNA dissection. Nucleic Acids Res.(2016); 44:1. [PMID: 26578605]
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297.
Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102-114.
Zhao H, Kalota A, Jin S, Gewirtz AM. The c-my proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. Blood. 2009;113(3): 505-516.
Sankaran VG, Menne TF, Scepanovic D, et al. MicroRNA-15a and -16- 1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci USA. 2011;108(4):1519-1524.
Lai K, Jia S, Yu S, Luo J, He Y. Genome-wide analysis of aberrantly expressed lncRNAs and miRNAs with associated co-expression And ceRNA networks in beta-thalassemia and hereditary persistence of fetal hemoglobin. Oncotarget. 2017;8(30):49931-49943.
Bartel DP .Metazoan microRNAs. Cell. 2018; 173: 20-51
Króliczewski J, Sobolewska A, Lejnowski D, Collawn JF, Bartoszewski R. microRNA Single Polynucleotide Polymorphism Influences on microRNA Biogenesis and mRNA Target Specificity. Gene (2018) 640:66–72. doi:10.1016/ j.gene.2017.10.021
Barati Z, Farsimadan M, Sharafshah A, Peymani M, Bijanzadeh M. Association Study of Rs10768683 and Rs968857 Polymorphisms with Transfusion-dependent Thalassemia (TDT) in a Southern Iranian Population. Nucleosides, Nucleotides and Nucleic Acids (2019) 38(1):88–99. doi:10.1080/15257770.2018.1498514
Shi Z, Zhao C, Guo X, Ding H, Cui Y, Shen R, et al. Differential Expression of MicroRNAs in Omental Adipose Tissue from Gestational Diabetes Mellitus Subjects Reveals miR-222 as a Regulator of ERα Expression in Estrogen-Induced Insulin Resistance. Endocrinology (2014) 155(5):1982–90. doi:10.1210/en.2013-2046
Huang H, Xu L, Chen M, et al. Molecular characterization of thalassemia and hemoglobinopathy in Southeastern China. Sci Rep. 2019;9(1):3493.
Marktel S, Scaramuzza S, Cicalese MP, et al. Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent β-thalassemia. Nat Med. 2019;25(2):234-241.
Ghaedi H ; Azarshin1, S.Z; Bijanzadeh. M; Shafiei, M. Polymorphism studies on microRNA targetome of thalassemia. Bioinformation (2018);14(5): 252-258.
Nuntakarn L et al. Blood Cells, Mol Dis. 2009 42:1. [PMID:18951049]
Moszynska A ; Gebert,M; Collawn,J.F; Bartoszewski,R. SNPs in microRNA target sites and their potential role in human disease Open Biol. 2017 7:4. [PMID: 28381629]
Eltaweel NH, ElKamah GY, Khairat R, Atia HAE, Amr KS. Epigenetic effects toward new insights as a potential therapeutic target in B-thalassemia. J Genet Eng Biotechnol. 2021;19:51.
Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322:1839-1842.
Sheinerman KS, Toledo JB, Tsivinsky VG, et al. Circulating brain enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimers Res Ther. 2017;9(1):89.
Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389‐402.
Fawzy MS, Toraih EA, Ibrahiem A, Abdeldayem H, Mohamed AO, Abdel‐Daim MM. Evaluation of miRNA‐196a2 and apoptosis-related target genes: ANXA1, DFFA and PDCD4 expression in gastrointestinal cancer patients: a pilot study. PLoS ONE. 2017;12(11):e0187310.
Zhu L, Chu H, Gu D, et al. A functional polymorphism in miRNA‐ 196a2 associated with colorectal cancer risk in a Chinese population. DNA Cell Biol. 2012;31(3):350‐354.
Zhang, W.; Zhang, C.; Chen, H.; Li L, Tu Y, Liu C, et al. Evaluation Of Micrornas Mir- 196a, Mir-30a-5p, And Mir-490 As Biomarkers Of Disease Activity Among Patients With Fsgs. Clin J Am Soc Nephrol (2014);9(9):1545–1552.
Ha, T.Y. MicroRNAs in human diseases: from lung, liver and kidney diseases to infectious disease, sickle cell disease and endometrium disease. Immune Netw. 2011; 11(6): 309-323
Stranger, B., Nica, A., Forrest, M . et al. (Population genomics of human gene expression. Nat Genet (2007);39, 1217–1224. https://doi.org/10.1038/ng2142
Searles, N. S; Gross, A; Camacho-Soto, A; Willis, A,W; Racette. B.A. β2-adrenoreceptor medications and risk of Parkinson's disease Annal of Neurology (2018);Volume 84, Issue 5 November Pages 683-693.
Olga P., Ancha B, and Mikhail S, “Comprehensive analysis of human microrna–mrna interactome,” Frontiers in Genetics (2019):, vol. 10,
Jameel, Z.I. Four microRNA gene polymorphisms are associated with Iraqi patients with colorectal cancer. Egypt J Med Hum Genet 25, 47 (2024). https://doi.org/10.1186/s43042-024-00521-6.
Abdul-Hadi Chabuk H, Jameel ZI (2021) Relationship between the monoamine oxidase gene overactivity and the otherpathophysiological and behavioral parameters implicated in memory deficiency in albino Winstar rats as Alzheimer’s diseasemodel. J Appl Nat Sci 13(4):1274–1282. https://doi.org/10.31018/jans.v13i4.3024
Jameel ZI, Lawi ZK, Al-Dujaili NH (2019) Investigation of micro RNA gene polymorphism (Rs11614913) inpatients with type 2 diabetes in Najaf City. Biochem Cell Arch 19(1):2027–2030 .
